viernes, 24 de octubre de 2025

TrumpRx and a most favored nation policy won’t lower prices for patients A better approach would be to fix the broken system around generics and biosimilars

https://www.statnews.com/2025/10/24/trumprx-most-favored-nation-drug-prices-generics-biosimilars/

No hay comentarios:

Publicar un comentario